CSIMarket


Revvity Inc  (PKI)
Other Ticker:  
 

Revvity Inc

PKI's Fundamental analysis








Revvity Inc's sales fell by -46.42 % in I. Quarter 2023 from the same quarter a year ago. Ranking at No. 1960

Biotechnology & Pharmaceuticals industry recorded deterioration of revenues by -13.44 %

Revvity Inc's net income grew by 221.81 % in I. Quarter 2023 year on year, above company average,

More on PKI's Growth


Revvity Inc
current PE on trailing twelve month basis is above Biotechnology & Pharmaceuticals industry average.

Revvity Inc PEG ratio is at 0.72 Company is currently trading with Price to Cash flow multiple of 12.37 in trailing twelve-month period.
Company
15.33
PE TTM   
Industry
-
PE TTM    
Company's Price to Sales ratio is at 5.34.
Biotechnology & Pharmaceuticals industry's Price to Sales ratio is at 5.95.


More on PKI's Valuation
 
 Total Debt (Millions $) 4,360
 Dividend TTM ($) 0.49 $
 Dividend Yield TTM (%) 0.24 %
 Revenue/Employee (TTM) $ 163,308
 Net Income/Employee (TTM) $ 57,586
 Receivable Turnover (TTM) 4.08
 Tangible Book Value (Per Share $) -13.97

Revvity Inc
current PE on trailing twelve month basis is above Biotechnology & Pharmaceuticals industry average.

Revvity Inc PEG ratio is at 0.72 Company is currently trading with Price to Cash flow multiple of 12.37 in trailing twelve-month period.
Company
15.33
PE TTM   
Industry
-
PE TTM    
Company's Price to Sales ratio is at 5.34.
Biotechnology & Pharmaceuticals industry's Price to Sales ratio is at 5.95.

Revvity Inc Price to Book Ratio is at 1.81 lower than Indusry Avg. of 4.19. and lower than S&P 500 Avg. of 1397.71

More on PKI's Valuation

  Market Capitalization (Millions $) 14,574
  Shares Outstanding (Millions) 126
  Employees 16,700
  Revenues (TTM) (Millions $) 2,727
  Net Income (TTM) (Millions $) 962
  Cash Flow (TTM) (Millions $) 1,178
  Capital Exp. (TTM) (Millions $) -77
  Total Debt (Millions $) 4,360
  Dividend TTM ($) 0.49 $
  Dividend Yield TTM (%) 0.24 %
  Revenue/Employee (TTM) $ 163,308
  Net Income/Employee(TTM) $ 57,586
  Receivable Turnover Ratio (TTM) 4.08
  Tangible Book Value (Per Share $) -13.97

  Market Capitalization (Millions $) 14,574
  Shares Outstanding (Millions) 126
  Employees 16,700
  Revenues (TTM) (Millions $) 2,727
  Net Income (TTM) (Millions $) 962
  Cash Flow (TTM) (Millions $) 1,178
  Capital Exp. (TTM) (Millions $) -77


    PKI's Profitability Comparisons
Revvity Inc faced margin deterioraten, primarily through cost pressure. Operating Margin fell in I. Quarter 2023 to 11.28 % from 113.7 % in IV. Quarter.

Revvity Inc net profit margin of 84.38 % is currently ranking no. 5 in Biotechnology & Pharmaceuticals industry, ranking no. 10 in Healthcare sector and number 77 in S&P 500.


Profitability by Segment
Human Health 18.38 %
Environmental Health 10.39 %



  Ratio
   Capital Ratio (MRQ) 2.43
  Total Debt to Equity (MRQ) 0.54
  Tangible Leverage Ratio (MRQ) -
  Asset Turnover Ratio (TTM) 0.19
  Inventory Turnover Ratio (TTM) 3.18



Revvity Inc faced margin deterioraten, primarily through cost pressure. Operating Margin fell in I. Quarter 2023 to 11.28 % from 113.7 % in IV. Quarter.

Revvity Inc net profit margin of 84.38 % is currently ranking no. 5 in Biotechnology & Pharmaceuticals industry, ranking no. 10 in Healthcare sector and number 77 in S&P 500.

More on PKI's Key Ratios





Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2023 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071